Malignant Hypercalcemia—a Hospital Survey
- 12 January 1986
- journal article
- research article
- Published by Wiley in Acta Medica Scandinavica
- Vol. 220 (5) , 455-463
Abstract
A hypercalcemia frequency of 1.5% was found in patients with malignant disease attending a large oncological center. Eighty per cent of hypercalcemias were of obvious malignant etiology. Hypercalcemia was most frequent in multiple myeloma, renal carcinoma, squa‐mocellular carcinomas of different sites and breast cancer. Most patients had advanced metastasized disease. In 80% of those with solid tumors malignant hypercalcemia was associated with bone metastases. Serum calcium could almost invariably be reduced by treatment, and active treatment was associated with a more favorable prognosis. One year actuarial survival of patients with malignant hypercalcemia was 31%.Keywords
This publication has 43 references indexed in Scilit:
- Mechanism of malignant hypercalcaemia in carcinoma of the breast.BMJ, 1985
- Tumor products and the hypercalcemia of malignancy.Journal of Clinical Investigation, 1985
- HYPERCALCAEMIA AND METASTASISThe Lancet, 1982
- HYPERCALCAEMIA IN HOSPITAL PATIENTS Clinical and Diagnostic AspectsThe Lancet, 1981
- Hypercalcemia in epidermoid tumors of the head and neck and esophagusCancer, 1973
- Hypercalcemia Complicating Breast CancerOncology, 1973
- Endocrine and metabolic disorders in bronchial carcinoma.BMJ, 1971
- Endocrine and Metabolic Disorders in Bronchial CarcinomaBMJ, 1970
- Bronchial carcinoma and hypercalcaemiaJournal of Clinical Pathology, 1969
- Hypercalcemia in Carcinoma of the BreastAnnals of Surgery, 1963